Valeant Said to Consider Sale of Paragon Unit, Reuters Reports

Valeant Pharmaceuticals International Inc. is considering selling a contact lens manufacturing division that has been under scrutiny by the Federal Trade Commission, Reuters reported Monday.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.